Diagnosis Criteria | Target district | Cut-off points | ||
---|---|---|---|---|
Muscle mass | Muscle strength | Muscle performance | ||
AGWS [20] | countries from Asia | ASM/height2 by DXA: (M: < 7.0 kg/m2, F: < 5.4 kg/m2); Or ASM/height2 by BIA: (M: < 7.0 kg/m2, F: < 5.7 kg/m2) | HGS: (M:< 28 kg, F:< 18 kg) | GS: < 1.0 m/s; Or 5-STS ≥ 12 s; Or SPPB: ≤9 |
EWGSOP-2019 [20] | countries from Europe | ASM/height2 by DAX or BIA: (M: < 7.0 kg/m2, F: < 6 kg/m2) | HGS: (M: < 27 kg, F: < 16 kg) | GS: < 0.8 m/s; or 5-STS > 15 s; or SPPB: ≤8; or TUG ≥20s |
EWGSOP-2010 [21] | countries from Europe | ASM/height [2] by DXA: (M: < 7.23 kg/m2, F: < 5.67 kg/m2); or ASM/height2 by BIA: (M: < 8.87 kg/m2, F: < 6.42 kg/m2) | HGS: (M: < 30 kg, F: < 20 kg) | GS: < 1.0 m/s; or SPPB: ≤8 |
FNIH [22] | / | ASM/BMI by DXA: (M: < 0.789, F: < 0.512) | HGS: (M: < 26 kg, F: < 16 kg) | / |
CDC [ 23] | New Mexico | [0.2487(weight) + 0.0483(height)- 0.1584(hip circumference) + 0.0732HGS + 2.5843(sex) + 5.8828] < 2 standard deviations of a young reference population | / | / |
Janssen [24] | United States | [(height2/BIA-resistance*0.401) + 3.825(gender) + 0.071(age) + 5.102]/body mass*100] < 1 standard deviations of a young reference population | / | / |
Tyrovolas [25] | countries from Asia, Africa, Europe, and Latin America | ASM/BMI by BIA, M: ≤0.93 kg/m2, F: ≤0.57 kg/m2; | HGS: (M: < 30 kg, F: < 20 kg) | GS: (M: 0.95–0.66 m/s; F:0.08–0.48 m/s) |
Chung [26] | Korea | ASM/weight2*100% by DXA, M: ≤32.5%, F: ≤25.7% | / | / |
Fried | United States | weight loss, of ≥10 pounds or, of ≥5% of body weight in prior year | HGS: lowest 20% | GS: slowest 20% |
Chen | China | ASM/height2 by DXA: (M: < 6.66 kg/m2, F: < 5.24 kg/m2); or SMM/weight: (M: < 37.15%, F: < 32.26%); or SMM/height2: (M: < 8.43 kg/m2, F: < 6.80 kg/m2) | / | / |